Opus Genetics, Inc. Derivative Liability, Current
Opus Genetics, Inc. (IRD) had Derivative Liability, Current of $21.32 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2025-11-12
- 2025-09-30: Derivative Liability, Current $21.32M.
- 2025-06-30: Derivative Liability, Current $11.80M.
- 2025-03-31: Derivative Liability, Current $12.71M.
- 2024-12-31: Derivative Liability, Current $0.00; Derivative Liability, Current as first filed $2.00K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2025-09-30 | $21.32M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $11.80M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $12.71M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-12 | $2.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $74.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $74.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $74.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $74.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $93.00K 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-08 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-11 | |
| 2019-12-31 | $2.71M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |